Related Experiment Video

Updated: Jun 3, 2025

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.4K

NEK2 Phosphorylates RhoGDI1 to Promote Cell Proliferation, Migration and Invasion Through the Activation of RhoA and

Jeewon Lim1,2, Yo-Sep Hwang1, Jong-Tae Kim1

  • 1Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.

Cells
|January 8, 2025
PubMed

Insights

Never In Mitosis A (NIMA)-related kinase 2 (NEK2) phosphorylates Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) at Ser174, promoting cancer cell proliferation and metastasis by activating RhoA and Rac1.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) regulates Rho GTPase activity, influencing cell proliferation and migration.
  • Phosphorylation of RhoGDI1 is a key mechanism for modulating Rho GTPase activation.

Purpose of the Study:

  • To investigate the role of Never In Mitosis A (NIMA)-related serine/threonine protein kinase 2 (NEK2) in phosphorylating RhoGDI1.
  • To determine the impact of NEK2-mediated RhoGDI1 phosphorylation on cancer cell behavior and tumor progression.

Main Methods:

  • GST pull-down assays and immunoprecipitation to confirm NEK2-RhoGDI1 interaction.
  • Truncation analysis to identify the RhoGDI1 binding region for NEK2.
  • Phosphorylation assays to pinpoint the NEK2 phosphorylation site on RhoGDI1.
  • Functional assays using RhoGDI1 mutants to assess effects on cancer cell proliferation and migration.

Main Results:

  • NEK2 directly binds and phosphorylates RhoGDI1 at Ser174.
  • The RhoGDI1 amino acid region 112-134 is crucial for NEK2 binding.
  • NEK2-induced RhoGDI1 phosphorylation activates RhoA and Rac1, enhancing cancer cell proliferation and motility.
  • Disrupting the NEK2-RhoGDI1 interaction reduces cancer cell proliferation, migration, tumor growth, and lung metastasis in vivo.

Conclusions:

  • NEK2 promotes cancer cell proliferation and metastasis by phosphorylating RhoGDI1, leading to RhoA and Rac1 activation.
  • Targeting the NEK2-RhoGDI1 interaction could be a therapeutic strategy to inhibit cancer progression.
Keywords:
NEK2Rho GTPaseRhoGDI1cancermigrationproliferation

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.0K
Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.4K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.7K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K